7 reports of this reaction
22.6% of all 5% LIDOCAINE reports
#1 most reported adverse reaction
PALLOR is the #1 most commonly reported adverse reaction for 5% LIDOCAINE, manufactured by 100 KARMA INC. There are 7 FDA adverse event reports linking 5% LIDOCAINE to PALLOR. This represents approximately 22.6% of all 31 adverse event reports for this drug.
Patients taking 5% LIDOCAINE who experience pallor should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PALLOR is a frequently reported adverse event for 5% LIDOCAINE, accounting for a significant proportion of all reports.
In addition to pallor, the following adverse reactions have been reported for 5% LIDOCAINE:
The following drugs have also been linked to pallor in FDA adverse event reports:
PALLOR has been reported as an adverse event in 7 FDA reports for 5% LIDOCAINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
PALLOR accounts for approximately 22.6% of all adverse event reports for 5% LIDOCAINE, making it one of the most commonly reported side effect.
If you experience pallor while taking 5% LIDOCAINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.